gut.bmj2d
Gallstones after ileostomy and ileal resection.
One hundred and eight patients with ileostomies were investigated for cholelithiasis at routine annual review in a large Ileostomy Clinic. Gallstones were demonstrated in 24-5%, which is three times ...
gut.bmj2d
O15 Patient perspectives of virtual mental health nurse based within a hepatology department within a general hospital setting
Liver disease is largely preventable with only approximately 5% of liver disease is attributable to autoimmune disorders (OHIED, 2023). People with the leading cause of cirrhosis, alcohol misuse, the ...
gut.bmj2d
PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis
Background Mounting epidemiological evidence supports a role for phosphatase and tensin homologue (PTEN)-T cell leukaemia 1 (Tcl1) signalling deregulation in hepatocarcinogenesis. Objective To ...
gut.bmj2d
Dynamic Radiology of the Abdomen: Normal and Pathologic Anatomy, 5th edn
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj2d
P14 Emotional eating and non-alcoholic fatty liver disease: a pre-registered questionnaire study in a clinical population
Background In Wales 61% of adults are overweight or living with obesity. Obesity is associated with non-alcoholic fatty liver disease (NAFLD), of which the incidence has increased 10-fold. NAFLD has ...
gut.bmj2d
P116 Incidence and risk factors for incisional hernias following liver transplantation: a retrospective single-centre study
Methods A retrospective analysis of LTs from the Birmingham Liver unit (January 2013 to May 2023) with a minimum follow-up of 6 months was performed. Risk factors present at listing were recorded ...
gut.bmj2d
P115 Radiological-histological discordance may predict outcomes in patients transplanted for HCC
Background and Aims Hepatocellular carcinoma (HCC) remains a leading cause of liver-related morbidity and mortality. Although liver transplantation (LT) is a radical therapy that improves survival, ...
gut.bmj2d
P73 The patient experience of a new ‘referral’ pathway for liver disease in the Somerset Liver Improvement Project
Introduction The Somerset Liver Improvement Project uses unique software to identify patients at risk of undiagnosed liver disease by analysing trends in prior blood tests. This is outside the ...
gut.bmj2d
P2 A regional evaluation of outcomes at three months for patients admitted to hospital with decompensated alcohol related cirrhosis
7 East Suffolk and North Essex NHS Foundation Trust, UK 8 West Suffolk NHS Foundation Trust, UK Introduction The UK guidelines on liver transplantation for alcohol related cirrhosis require patients ...
gut.bmj3d
P44 Clinical outcomes, safety and length of stay for patients receiving transarterial chemoembolisation (TACE): a retrospective audit
Introduction Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer, 90% of cases are associated with chronic liver disease. Early detection and management of HCC remain ...
gut.bmj3d
P130 Experience of active hepatitis C prevalence in liverpool city centre as determined by ED reflexive testing; reflections on how we got here
In 2019, a multi-centred UK study procured residual blood samples from several ED sites, including Liverpool, finding high levels of active HCV, often in patients unaware of their HCV status. ED ...
gut.bmj3d
P128 Defining the data requirement to achieve hepatitis C elimination in the United Kingdom: the somerset liver improvement project
Introduction Despite treatment initiatives to meet the WHO target of eliminating hepatitis C virus (HCV) by 2030, many patients with HCV in the UK are not yet linked to specialist services or treated.